Comparative Outcomes of a Transthyretin Amyloid Cardiomyopathy Cohort Versus Patients With Heart Failure With Preserved Ejection Fraction Enrolled in the TOPCAT Trial.

Kim, Morris M; Prasad, Mark; Burton, Yunwoo; Kolseth, Clinton M; Zhao, Yuanzi; Chandrashekar, Pranav; Nazer, Babak; Masri, Ahmad

Kim, Morris M; Prasad, Mark; Burton, Yunwoo; Kolseth, Clinton M; Zhao, Yuanzi; Chandrashekar, Pranav; Nazer, Babak; Masri, Ahmad.

Affiliation

Kim MM; Center for Amyloidosis, Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA.
Prasad M; Center for Amyloidosis, Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA.
Burton Y; Center for Amyloidosis, Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA.
Kolseth CM; Center for Amyloidosis, Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA.
Zhao Y; Center for Amyloidosis, Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA.
Chandrashekar P; Center for Amyloidosis, Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA.
Nazer B; Division of Cardiology University of Washington Seattle WA USA.
Masri A; Center for Amyloidosis, Knight Cardiovascular Institute Oregon Health & Science University Portland OR USA.

J Am Heart Assoc ; 12(15): e029705, 2023 08.

Article de En | MEDLINE | ID: mdl-37522238

Sujet(s)
Mots clés

ATTR cardiomyopathy; cardiac amyloidosis; heart failure with preserved ejection fraction

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Défaillance cardiaque / Amyloïdose / Cardiomyopathies Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: J Am Heart Assoc Année: 2023 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google